| # | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. |  ALA4745071 | EUB0000337aCl | % of control | = | 69 | % | ALA5214347 | % | Homo sapiens | |||
| 2. |  ALA4445335 | Roxyl-ZV-5J | INH | = | 0 | % | ALA4408137 | % | Homo sapiens | |||
| 3. |  ALA4455923 | 48c | INH | < | 50 | % | ALA4405568 | % | Homo sapiens | |||
| 4. |  ALA4559936 | (+/-)-6 | Activity | = | 100 | % | ALA4391590 | % | Homo sapiens | |||
| 5. |  ALA4564973 | 50 | INH | = | 88 | % | ALA4389964 | % | Homo sapiens | |||
| 6. |  ALA4555459 | 43 | INH | = | 86 | % | ALA4389487 | % | Homo sapiens | |||
| 7. |  ALA4473365 | 7c | Activity | = | 72 | % | ALA4382768 | % | Homo sapiens | |||
| 8. |  CDK9-IN-7 | 21e | INH | = | 7 | % | ALA4377908 | % | Homo sapiens | |||
| 9. |  ALA2348350 | 15u | Activity | = | 75 | % | ALA4806777 | % | Homo sapiens | |||
| 10. | ALA2348350 | 15u | Activity | = | 100 | % | ALA4806777 | % | Homo sapiens | |||
| 11. |  Meisoindigo | 2 | Activity | = | 81 | % | ALA4806212 | % | Homo sapiens | |||
| 12. |  ALA4870304 | IV | Activity | = | 78 | % | ALA4805760 | % | Homo sapiens | |||
| 13. |  ALA4878072 | Senexin C/6148/GJ-2331/2335 | Activity | = | 75 | % | ALA4805172 | % | Homo sapiens | |||
| 14. |  ALA4859660 | I-9 | INH | = | 35 | % | ALA4804678 | % | Homo sapiens | |||
| 15. |  ALA4868141 | I-65 | INH | = | 0 | % | ALA4804678 | % | Homo sapiens | |||
| 16. |  ALA4855730 | I-51 | INH | = | 0 | % | ALA4804678 | % | Homo sapiens | |||
| 17. |  ALA4867931 | I-50 | INH | = | 0 | % | ALA4804678 | % | Homo sapiens | |||
| 18. |  ALA4860979 | I-28 | INH | = | 0 | % | ALA4804678 | % | Homo sapiens | |||
| 19. |  ALA4855542 | I-13 | INH | = | 0 | % | ALA4804678 | % | Homo sapiens | |||
| 20. | ALA4859660 | I-9 | % inhibition | = | 43.7 | uM | ALA4804496 | Data is reported as I50 but values are consistent with % inhibition, changed for ChEMBL32 at suggestion of BZ | uM | Homo sapiens |
The page will load shortly, Thanks for your patience!